Risk Factors for Colorectal Adenoma and Cancer in Comprehensive Health Checkups: Usefulness of Gamma-Glutamyltransferase

Overview

Journal J Pers Med

Date 2024 Nov 26

PMID 39590574

Authors

Yoko Yamanouchi

Maiko Osawa

Takaaki Senbonmatsu

Yuki Shiko

Yohei Kawasaki

Toshihiro Muramatsu

Affiliations

Soon will be listed here.

Abstract

Background/objectives: In this study, we aimed to determine the risk factors for colorectal adenoma/cancer by studying patients who underwent comprehensive health checkups and were referred to a hospital because of positive fecal occult blood.

Methods: A total of 529 patients were referred to hospital for a positive fecal occult blood test after a comprehensive health checkup at the participating center over a period of 5 years, from January 2018 to December 2022. Patients diagnosed with colorectal adenoma or cancer using colonoscopy were included in the case group, while those diagnosed with no abnormality, diverticulum, or hemorrhoids were included in the control group.

Results: Of the 529 referred patients, 503 underwent colonoscopy. A total of 18 colorectal cancers and 191 colorectal adenomas were detected, and there were no tumors, diverticula, or hemorrhoids in any of the 208 patients. Polyps, either hyperplastic or of unknown pathology, were found in 86 patients. A comparison of the case and control groups showed that gamma-glutamyltransferase (GGT) was an independent and significant risk factor for colorectal adenoma or cancer, in addition to previously known risk factors such as male sex, older age, high body mass index, and alcohol consumption.

Conclusions: For patients with a positive fecal occult blood test, in addition to traditional risks such as obesity, older age, male sex, and alcohol consumption, identifying those with high GGT levels is recommended to help find colorectal adenoma/cancer.

Citing Articles

Correlation Between Skeletal Muscle Mass and Different Pathological Types of Colorectal Polyp in Chinese Asymptomatic Population.

Li W, Wang N, Ye H, Chen M Int J Gen Med. 2025; 18:927-938.

PMID: 39995636 PMC: 11849526. DOI: 10.2147/IJGM.S503137.

References

Wang H, Zheng H, Cao X, Meng P, Liu J, Zuo H . Association between serum γ-glutamyl transferase and advanced colorectal adenoma among inpatients: a case-control study. Front Oncol. 2024; 13:1188017. PMC: 10816217. DOI: 10.3389/fonc.2023.1188017. View

Fonseca A, Ramao A, Burger M, de Souza J, Zanette D, de Molfetta G . ETV4 plays a role on the primary events during the adenoma-adenocarcinoma progression in colorectal cancer. BMC Cancer. 2021; 21(1):207. PMC: 7919324. DOI: 10.1186/s12885-021-07857-x. View

Nakai K, Watari J, Tozawa K, Tamura A, Hara K, Yamasaki T . Sex differences in associations among metabolic syndrome, obesity, related biomarkers, and colorectal adenomatous polyp risk in a Japanese population. J Clin Biochem Nutr. 2018; 63(2):154-163. PMC: 6160732. DOI: 10.3164/jcbn.18-11. View

Shen H, Lipka S, Kumar A, Mustacchia P . Association between nonalcoholic fatty liver disease and colorectal adenoma: a systemic review and meta-analysis. J Gastrointest Oncol. 2014; 5(6):440-6. PMC: 4226833. DOI: 10.3978/j.issn.2078-6891.2014.061. View

Malnick S, Alin P, Somin M, Neuman M . Fatty Liver Disease-Alcoholic and Non-Alcoholic: Similar but Different. Int J Mol Sci. 2022; 23(24). PMC: 9783455. DOI: 10.3390/ijms232416226. View

Corti A, Franzini M, Paolicchi A, Pompella A . Gamma-glutamyltransferase of cancer cells at the crossroads of tumor progression, drug resistance and drug targeting. Anticancer Res. 2010; 30(4):1169-81. View

Xing M, Gao M, Li J, Han P, Mei L, Zhao L . Characteristics of peripheral blood Gamma-glutamyl transferase in different liver diseases. Medicine (Baltimore). 2022; 101(1):e28443. PMC: 8735790. DOI: 10.1097/MD.0000000000028443. View

Leslie A, Carey F, Pratt N, Steele R . The colorectal adenoma-carcinoma sequence. Br J Surg. 2002; 89(7):845-60. DOI: 10.1046/j.1365-2168.2002.02120.x. View

Giovannucci E . Modifiable risk factors for colon cancer. Gastroenterol Clin North Am. 2002; 31(4):925-43. DOI: 10.1016/s0889-8553(02)00057-2. View

10.

Basyigit S, Uzman M, Kefeli A, Sapmaz F, Yeniova A, Nazligul Y . Absence of non-alcoholic fatty liver disease in the presence of insulin resistance is a strong predictor for colorectal carcinoma. Int J Clin Exp Med. 2016; 8(10):18601-10. PMC: 4694373. View

11.

Lee H, Lee H, Kim S, Kim H . Metabolic Dysfunction-Associated Fatty Liver Disease Increases Colon Cancer Risk: A Nationwide Cohort Study. Clin Transl Gastroenterol. 2022; 13(1):e00435. PMC: 8806363. DOI: 10.14309/ctg.0000000000000435. View

12.

Toya D, Sawabu N, Ozaki K, Wakabayashi T, Nakagen M, Hattori N . Purification of gamma-glutamyltranspeptidase (gamma-GTP) from human hepatocellular carcinoma (HCC), and comparison of gamma-GTP with the enzyme from human kidney. Ann N Y Acad Sci. 1983; 417:86-96. DOI: 10.1111/j.1749-6632.1983.tb32852.x. View

13.

Gong Y, Kang J, Wang X, Zheng Y, Sui Y, Lu W . Increased detection rates of advanced colorectal adenoma in women with metabolic dysfunction-associated fatty liver disease. Heliyon. 2023; 9(11):e22391. PMC: 10689946. DOI: 10.1016/j.heliyon.2023.e22391. View

14.

Irie M, Suzuki N, Sohda T, Anan A, Iwata K, Takeyama Y . Hepatic expression of gamma-glutamyltranspeptidase in the human liver of patients with alcoholic liver disease. Hepatol Res. 2007; 37(11):966-73. DOI: 10.1111/j.1872-034X.2007.00151.x. View

15.

Lesmana C, Pakasi L, Sudoyo A, Krisnuhoni E, Lesmana L . The Clinical Significance of Colon Polyp Pathology in Nonalcoholic Fatty Liver Disease (NAFLD) and Its Impact on Screening Colonoscopy in Daily Practice. Can J Gastroenterol Hepatol. 2020; 2020:6676294. PMC: 7746467. DOI: 10.1155/2020/6676294. View

16.

Pyo J, Hong S, Min B, Kyung Chang D, Son H, Rhee P . Is height a risk factor for colorectal adenoma?. Korean J Intern Med. 2015; 31(4):653-9. PMC: 4939489. DOI: 10.3904/kjim.2014.313. View

17.

Sninsky J, Shore B, Lupu G, Crockett S . Risk Factors for Colorectal Polyps and Cancer. Gastrointest Endosc Clin N Am. 2022; 32(2):195-213. DOI: 10.1016/j.giec.2021.12.008. View

18.

Harrell Jr F, Lee K, Mark D . Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med. 1996; 15(4):361-87. DOI: 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4. View

19.

Lee Y, Lim Y, Park H . Colorectal neoplasms in relation to non-alcoholic fatty liver disease in Korean women: a retrospective cohort study. J Gastroenterol Hepatol. 2011; 27(1):91-5. DOI: 10.1111/j.1440-1746.2011.06816.x. View

20.

Ze E, Kim B, Jun D, Kim J, Kang H, Lee D . The Fatty Liver Index: A Simple and Accurate Predictor of Colorectal Adenoma in an Average-Risk Population. Dis Colon Rectum. 2017; 61(1):36-42. PMC: 5728585. DOI: 10.1097/DCR.0000000000000973. View